LTFS
CTXR icon

Ladenburg Thalmann Financial Services’s Citius Pharmaceuticals CTXR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Hold
40
– – ﹤0.01% 5178
2019
Q3 		$1K Hold
40
– – ﹤0.01% 5091
2019
Q2 		$1K Hold
40
– – ﹤0.01% 5089
2019
Q1 		$1K Sell
40
-80
-67% -$2.35K ﹤0.01% 5056
2018
Q4 		$3K Hold
120
– – ﹤0.01% 4750
2018
Q3 		$5K Buy
+120
New +$5.73K ﹤0.01% 4586

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWM
Argent Wealth Management Waltham, Massachusetts $602M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CTXR Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Citius Pharmaceuticals (CTXR) position steady in Q4 2019 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5178.

Ladenburg Thalmann Financial Services first reported a position in CTXR in Q3 2018 and has held it in 6 quarters since. The position peaked at $5K in Q3 2018. 9 funds tracked by Wall St. Rank hold CTXR as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 40 shares of Citius Pharmaceuticals worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Citius Pharmaceuticals share count unchanged in Q4 2019.
  • Citius Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5178 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Citius Pharmaceuticals in Q3 2018 and has held it in 6 quarters since.
  • Ladenburg Thalmann Financial Services's Citius Pharmaceuticals position peaked at $5K in Q3 2018.
  • 9 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.